RxDoctor Payments Data

Mbettie Worrell

Family · Phoenixville, PANPI 1013231372

Payments from drug & device makers

$857in general payments, 2019–2025

Across 52 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$242
  • Novo Nordisk$114
  • Merck$58
  • Abbott$45
  • Astellas Pharma US Inc$45
  • Amgen$42
  • plus $311 from 12 others

What the payments were for

  • Food & beverage$857100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$857 in reported general payments places this provider in the 70th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$48,245
Medicare patients
232
Services billed
806

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban34$30,653
OzempicSemaglutide21$19,971
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$16,537
Albuterol Sulfate HfaAlbuterol Sulfate56$1,990
Fluticasone-SalmeterolFluticasone Propion/Salmeterol23$1,462
PaxlovidNirmatrelvir/Ritonavir12$1,429
Atorvastatin Calcium98$1,165
Pantoprazole Sodium91$900
Amlodipine Besylate104$756
Losartan Potassium41$682
Famotidine30$675
Levothyroxine Sodium51$556
Montelukast Sodium15$520
Fenofibrate11$485
Rosuvastatin Calcium44$464

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$40$32,08246 claims
Novo NordiskOzempic$114$19,97121 claims
GSKTrelegy Ellipta$22$16,53720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,717 family providers in Pennsylvania.

Other family in Phoenixville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →